Tech Company Financing Transactions
Numares Health Funding Round
Numares Health closed a $42.5 million funding round on 12/21/2022. Backers included European Investment Bank.
Transaction Overview
Company Name
Announced On
12/21/2022
Transaction Type
Venture Equity
Amount
$42,450,000
Round
Undisclosed
Investors
European Investment Bank (Lead Investor)
Proceeds Purpose
The European Investment Bank provided un up to �20m quasi equity financing for further research and development. Existing investors will contribute a complementary �20m for marketing investments to achieve mass commercialization of the proprietary technology products in the EU and U.S.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Am BioPark 9
Regensburg, 93053
DE
Regensburg, 93053
DE
Phone
Website
Email Address
Overview
We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that cannot be addressed by single biomarker-based medicine. numares has developed a versatile platform technology for developing innovative diagnostic tests based on the differences in the metabolism of people with and without a particular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Winton Gibbons
VP - Product Management
Katja Barthelmes
Browse more venture capital transactions:
Prev: 12/21/2022: Fiscozen venture capital transaction
Next: 12/21/2022: Treblle venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs